Target intelligence / Profile preview

DEAD-box helicase 3 X-linked (DDX3X) (DDX3X)

Target
DDX3X
Molecular classification
Enzyme, RNA helicase, DEAD-box helicase family, Superfamily 2 (SF2) helicase
01

Overview

DEAD-box helicase 3 X-linked (DDX3X) is a multifunctional ATP-dependent RNA helicase belonging to the DEAD-box protein family [4, 9]. It plays a central role in nearly all aspects of RNA metabolism, including transcription, pre-mRNA splicing, mRNA export, and translation initiation, particularly for mRNAs with complex 5' untranslated regions [11, 12]. Beyond its core RNA-processing functions, DDX3X is a key regulator of cellular signaling pathways such as Wnt/beta-catenin and NF-kappaB, and it is involved in the formation of stress granules and the innate immune response [5, 10, 18]. In oncology, DDX3X is frequently overexpressed and acts as an oncogene in various cancers, including breast, colorectal, and glioblastoma, where it promotes cell proliferation and metastasis [1, 13, 15]. Conversely, it can act as a tumor suppressor in certain contexts, such as in some cases of hepatocellular carcinoma [25, 27]. DDX3X is also a critical host factor for the replication of numerous viruses, including HIV-1, HCV, and SARS-CoV-2, making it a promising target for broad-spectrum antiviral therapy [6, 10, 29]. Small molecule inhibitors like RK-33 and BA103 are being developed to target its ATPase or helicase activities to treat cancer and viral infections [1, 31].

Other names
DDX3DBXHLP2DDX14CAP-RfMRX102MRXSSBDEAD-box polypeptide 3 X-linkedATP-dependent RNA helicase DDX3X
02

Mechanism of action

Inhibition of the ATP-binding site (ATPase activity) or the RNA-binding site (helicase activity), leading to suppressed mRNA translation of oncogenic proteins, disruption of Wnt/beta-catenin signaling, and induction of the innate immune response [1, 13, 15, 30].

03

Biological functions

mRNA translation initiation (5' UTR scanning) [4, 11, 12]Alternative pre-mRNA splicing [4, 9, 26]mRNA nuclear export [4, 12]Transcription regulation [4, 9]Wnt/beta-catenin signaling pathway activation [1, 7, 22]NF-kappaB signaling regulation [10, 17]Stress granule formation and dynamics [4, 5, 10]Innate immune response (RIG-I and NLRP3 pathways) [5, 6, 18]
04

Disease associations

Cancer (Breast, Colorectal, Medulloblastoma, Lymphoma, Glioblastoma, Oral, Lung, Prostate) [1, 2, 7, 13, 15, 22, 24, 31]Viral infection (HIV-1, HCV, HBV, SARS-CoV-2, Zika, West Nile virus) [6, 10, 12, 29]Neurodevelopmental disorder (DDX3X syndrome/Intellectual disability) [8, 19, 32]
05

Safety considerations

Potential for systemic toxicity due to the essential role of DDX3X in normal cell survival and RNA metabolism [2, 13]Risk of neurotoxicity or developmental defects given its critical role in brain development [8, 19]Context-dependent tumor-suppressive functions that could lead to adverse effects in certain tissues if inhibited [25, 27]Off-target effects due to the high conservation of the ATP-binding site across the DEAD-box helicase family [13, 30]
06

Interacting drugs

RK-33 [1, 7, 29]

6 more in the full profile.

07

Biomarkers

DDX3X protein expression levels (IHC) [1, 7, 24]Nuclear beta-catenin localization [1, 7, 14]DDX3X somatic mutations (e.g., in medulloblastoma or Burkitt lymphoma) [2, 22, 33]Stress granule presence [4, 22]

Beyond the preview

Go deeper on DEAD-box helicase 3 X-linked (DDX3X) (DDX3X).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEAD-box helicase 3 X-linked (DDX3X) (DDX3X).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call